Browse studies

Find your next paid study

3,232 recruiting studies matching your filters

Piloting an Intervention to Improve Adjuvant Endocrine Therapy Adherence in Patients With Breast Cancer in Rwanda

This study aims to evaluate a multi-modal intervention designed to improve adherence to adjuvant endocrine therapy (AET) among patients with ER-positive breast…

Medication AdherenceBreast Cancer

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Dana-Farber Cancer InstituteNCT07562399

Data Collection Study of Pediatric and Adolescent Gynecology Conditions

Background: Gynecologic conditions are those that are related to the reproductive system. They can be reproductive gland disorders or reproductive system tumo…

Disorders of Sex Development (DSD)Pediatric and Adolescent Cancers of the Genital TractReproductive Endocrine Conditions in Puberty+1 more

Estimated

~$10 – $675

Actual pay is set by the research site.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT04717349

Phase 3

A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-centre, Global Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer Who Have Not Progressed Following Platinum-based, Concurrent Chemoradiation Therapy (eVOLVE-Cervical)

This is a phase III, randomized, double-blind, placebo-controlled, multi-center, global study to explore the efficacy and safety of volrustomig in women with h…

Locally Advanced Cervical Cancer

Estimated

~$50 – $2,250

Actual pay is set by the research site.

AstraZenecaNCT06079671

Observational

Prospective, Multicenter, Single Arm Feasibility and Safety Study of the Axonics External Trial System (ETS-02)

Evaluation of the new Axonics External Trial System (ETS-02) in patients with overactive bladder (OAB) and/or fecal incontinence (FI).

Urinary Urge Incontinence (UUI)Urinary Frequency (UF)Fecal Incontinence (FI)+1 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Axonics, Inc.NCT07335484

Observational

Post-Market Clinical Follow-up Study of the Rechargeable Axonics SNM System Model 5101 (R20) for the Indication of Overactive Bladder (OAB)

Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the Axonics SNM System INS Model 5101.

Urinary Urge Incontinence (UUI)Urinary Frequency (UF)Overactive Bladder (OAB)

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Axonics, Inc.NCT06789406

Observational

CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD

The purpose of this study is to examine whether youth with OCD who benefit from CBT augmentation to SRI can discontinue their medication without relapse over 2…

Cognitive Behavioral TherapyObsessive-Compulsive DisorderObsessive-Compulsive Disorder in Children+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Baylor College of MedicineNCT05609916

Phase 2

STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)

To learn if ivonescimab can help to control previously treated, locally advanced or metastatic ACC or PPGL.

Adrenocortical CarcinomaPheochromocytomaParaganglioma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07743138

Familial Investigations of Childhood Cancer Predisposition

NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may recei…

Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more

Estimated

~$10 – $750

Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy

This study evaluates changes in skin quality and self-esteem among breast cancer patients who are initiating aromatase inhibitor therapy.

Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+4 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT06401889

Phase 2

A Phase 2 Trial of Trastuzumab Deruxtecan in Combination With Cetuximab in HER2-low Metastatic Colorectal Cancer That Has Progressed on Standard Therapies

The purpose of this study is find out whether the combination of trastuzumab deruxtecan (T-DXd) and cetuximab is an effective treatment for participants with m…

Colorectal CancerAdenocarcinoma of the ColonAdenocarcinoma of the Rectum

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT07691489

Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) is a condition with several causes of which some remain unknown. It is believed that some types of C…

Chronic Prostatitis (CP)Chronic Pelvic Pain Syndrome (CPPS)Painful Bladder Syndrome (PBS)+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Children's HospitalNCT00499317

A Retrospective/Prospective Study of an Artificial Intelligence Derived Histological Biomarker to Select Neoadjuvant Treatment for Patients With Borderline Resectable or Resectable Pancreatic Ductal Adenocarcinoma

To collect samples and information from patients who will be undergoing standard of care neoadjuvant treatment with either FOLFIRINOX or Gemcitabine + Nab-pacl…

Pancreatic Ductal Adenocarcinoma

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Roswell Park Cancer InstituteNCT06320717